Navigation Links
Shire to Present New Scientific Data on its ADHD Treatments at a Major Psychiatric Meeting
Date:10/22/2007

octor before using DAYTRANA if the child: is being treated for or has symptoms of depression (e.g. sadness, worthlessness, or hopelessness) or bipolar disorder; has family history of tics; has abnormal thoughts or visions, hears abnormal sounds, or has been diagnosed with psychosis; has had seizures or abnormal EEGs; has or has had high blood pressure; exhibits aggressive behavior or hostility. Tell your doctor immediately if the child develops any of these conditions/symptoms while using Daytrana.

In clinical studies, side effects were generally mild to moderate. The most common side effects reported with DAYTRANA were decreased appetite, sleeplessness, sadness/crying, twitching, weight loss, nausea, vomiting, tics, and affect lability (mood swings). Aggression, new abnormal thoughts/behaviors, mania, and growth suppression have been associated with use of drugs of this type. Tell your doctor if the child has blurred vision while using DAYTRANA.

Abuse of DAYTRANA can lead to dependence.

DAYTRANA should be applied daily to clean, dry skin, which is free of any cuts or irritation. Skin irritation or allergic skin rash may occur.

For Full Prescribing Information go to http://www.DAYTRANA.com.

SHIRE PLC

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the extent opportunities arise through acquisitions. Shire's in-licensing, merger and acquisition efforts are focused on products in niche markets with strong intellectual property protection either in the US or Europe. Shire believes that a carefully selected portfolio of products with strategicall
'/>"/>

SOURCE Shire plc
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Wrong Vaccination given during surgery in Derbyshire
2. More Study On Side Effects of ADHD Drug Needed: Shire Pharmaceuticals
3. Yorkshire hit by a different ball game: fish disease
4. The Lachlan Shire Council To Fund GP For Condobolin Health Service
5. Shire Developed DAYTRANA – The First Medication to Treat ADHD Symptom
6. Poor Health of people in Central Goldfields Shire, reports The Victorian Burden of Disease
7. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
8. Researchers Present Ways To Reduce The Risk Of Dementia
9. Researchers Present Data Regarding The Efficiency Of Herbs
10. Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions
11. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... Angeles, CA (PRWEB) September 02, 2014 ... article on its website titled “Why You Should Wash ... than 80 percent of the global population breathes air ... and particles of pollution lodge in the skin’s pores ... body’s natural barrier to free radicals that may cause ...
(Date:9/2/2014)... groundwork for their own spread throughout the body by ... signals, according to a new report by Johns Hopkins ... Nature Communications , the researchers describe animal and ... molecules released by breast cancer cells. These molecules cause ... nodes to produce proteins called CCL5 and VEGF. CCL5 ...
(Date:9/2/2014)... By Kathleen Doheny ... -- The U.S. obesity epidemic is a driving force behind ... new study. Researchers looked at data from five national ... the increase in diabetes over time could be explained by ... in U.S. adults. The investigators found that the prevalence ...
(Date:9/2/2014)... News) -- A leading group of oncologists has released ... of advanced breast cancer. HER2-negative breast tumors ... the HER2 protein, the American Society of Clinical Oncology ... Almost 80 percent of women with advanced breast cancer ... this guideline, our aim is to improve both the ...
(Date:9/2/2014)... research on sleep apnea, tonsillectomies, hearing loss, head ... be presented in Orlando, FL, September 21-24, at ... the American Academy of OtolaryngologyHead and Neck Surgery ... nose, throat, head and neck physicians in the ... presented were released today, and are available online ...
Breaking Medicine News(10 mins):Health News:Simon Ourian, Kim Kardashian’s Doctor: Air Pollution May Be Aging Your Skin 2Health News:‘Prepped’ by tumor cells, lymphatic cells encourage breast cancer cells to spread 2Health News:Obesity Fueling Rise in Diabetes Rates, Study Finds 2Health News:Obesity Fueling Rise in Diabetes Rates, Study Finds 3Health News:New Guidelines for Treating Form of Advanced Breast Cancer 2
... women with a common thyroid problem may have a ... ,Studies in the past have shown that one of ... Although animal studies found mammary gland cells responded to ... in the relationship between thyroid hormone and breast cancer. ...
... allergen found in the air in many inner-city homes ... in children say researchers. ,According to researchers children ... allergy-causing substance found in mouse urine that is circulating ... developing allergic sensitivity to mice, just as it does ...
... live their lives by their sports drinks and energy drinks ... athletic achievements. //According to a study published in the January ... dental enamel is caused by bottled lemonade, sports drinks and ... enamel by these drinks are as much as 11 times ...
... there are actually scientific reasons why children may be ... strong // sweet tooth. Researchers found variation in a ... and adults. Age and culture also contribute to taste ... the study researchers compared taste sensitivity and food-related behaviors ...
... to evaluate the effect of diseases on contact with children ... were less likely to get the kind of affection other ... HIV-positive parents report avoided certain types of physical contact with ... to their children or pick up infections from the kids ...
... gum disease are more likely to suffer from atherosclerosis, or ... attack // or stroke shows latest research . ... mouths of 657 people who had no history of heart ... used to identify atherosclerosis, was also measured. People with a ...
Cached Medicine News:
(Date:9/2/2014)... , Sept. 2, 2014  XBiotech announced ... study being conducted in the US for its ... Human™ monoclonal antibody therapy, is being evaluated in ... complicated with cachexia. The primary endpoint of the ... treated patients to a control population provided only ...
(Date:9/2/2014)... , Sept. 2, 2014 Reportlinker.com announces ... in its catalogue: Acute Heart Failure ... http://www.reportlinker.com/p0689743/Acute-Heart-Failure-Global-Clinical-Trials-Review-H2-2014.html Acute Heart ... Summary GlobalData,s clinical trial report, "Acute ... provides data on the Acute Heart Failure clinical ...
(Date:9/2/2014)... 2014 According to a ... "Latin America Home Healthcare Market (By Device Types: ... Mobility Assist Devices and Medical Supplies; By Services: ... and Unskilled Home Healthcare Services) - Industry Analysis, ... 2020" the Latin American Home Healthcare market was ...
Breaking Medicine Technology:XBiotech Halts Study, Reports Positive Phase III Results with Antibody Therapy for Cancer 2Acute Heart Failure Global Clinical Trials Review, H2, 2014 2Acute Heart Failure Global Clinical Trials Review, H2, 2014 3Acute Heart Failure Global Clinical Trials Review, H2, 2014 4Acute Heart Failure Global Clinical Trials Review, H2, 2014 5Acute Heart Failure Global Clinical Trials Review, H2, 2014 6Acute Heart Failure Global Clinical Trials Review, H2, 2014 7Acute Heart Failure Global Clinical Trials Review, H2, 2014 8Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 2Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 3Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 4Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 5Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 6
... 27 Tengion, Inc. (Nasdaq: TNGN ), ... its first Analyst and Investor Meeting which was held ... and discussions of milestones and key data for the ... archive of the event and presentation materials will be ...
... DEL REY, Calif., Oct. 27 Prostate Oncology Specialists, ... sites in the nation to treat advanced prostate cancer ... therapeutic class known as autologous cellular immunotherapies.  PROVENGE was ... for the treatment of men with asymptomatic or minimally ...
Cached Medicine Technology:Tengion Reviews Pipeline Progress at First Analyst and Investor Meeting; Strategic & Clinical Updates Provided for Regenerative Medicine Programs 2Tengion Reviews Pipeline Progress at First Analyst and Investor Meeting; Strategic & Clinical Updates Provided for Regenerative Medicine Programs 3Tengion Reviews Pipeline Progress at First Analyst and Investor Meeting; Strategic & Clinical Updates Provided for Regenerative Medicine Programs 4Tengion Reviews Pipeline Progress at First Analyst and Investor Meeting; Strategic & Clinical Updates Provided for Regenerative Medicine Programs 5Prostate Oncology Specialists Among First in the Nation to Treat Advanced Prostate Cancer Patients With PROVENGE 2Prostate Oncology Specialists Among First in the Nation to Treat Advanced Prostate Cancer Patients With PROVENGE 3Prostate Oncology Specialists Among First in the Nation to Treat Advanced Prostate Cancer Patients With PROVENGE 4
...
For the qualitative detection of Wuchereria bancrofti antigen in whole blood, serum and plasma specimens...
For the qualitative detection of Hepatitis B surface Antigen (HBsAG) in human serum, plasma and whole blood specimens...
For the qualitative detection of Hepatitis B surface Antigen (HBsAG) in human serum, plasma and whole blood specimens...
Medicine Products: